Jasper Therapeutics, Inc.
JSPR
$5.40
$0.020.37%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
4/22/2025
-
Invezz News
4/16/2025
-
Ticker Report
4/13/2025
-
MarketBeat
4/3/2025
-
ETF Channel
3/23/2025
-
Ticker Report
3/19/2025
-
Zolmax
3/19/2025
-
MarketBeat
3/19/2025
-
The Fly
3/17/2025
-
MarketBeat
3/12/2025
-
MarketBeat
3/2/2025
-
TipRanks Financial Blog
3/2/2025
-
The Fly
3/1/2025
-
GuruFocus
3/1/2025
-
TipRanks Financial Blog
3/1/2025
-
GuruFocus
3/1/2025
-
Globe Newswire
3/1/2025
-
MarketBeat
2/28/2025
-
GuruFocus
2/28/2025
-
Globe Newswire
2/27/2025
-
The Fly
2/27/2025
-
GuruFocus
2/27/2025
-
Globe Newswire
2/25/2025
-
GuruFocus
2/25/2025
-
Globe Newswire
2/24/2025
-
MarketBeat
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Friday, February 28, 2025
Period Date
Tuesday, December 31, 2024
Next Filing
Week of May 12 and 16 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
--
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
650 549 1400
Address
2200 Bridge Pkwy
Redwood City, CA 94065
Redwood City, CA 94065
Country
Year Founded
--
Business Description
Sector
Jasper Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing therapeutics targeting mast and hematopoietic stem cell driven diseases. The company’s lead product...
more